Science Explorer Back to mapMap
Discussion
Researcher · Cold Spring Harbor Laboratory · United States

Lloyd C. Trotman

Lloyd C. Trotman publishes mostly in Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, on topics such as PI3K/AKT/mTOR signaling in cancer, Prostate Cancer Treatment and Research and Ubiquitin and proteasome pathways.

ORCID 0000-0002-4794-1559 OpenAlex
World rank
#167,390
of 7,710,434 ranked researchers
Rank in United States
#62,729
of 1,627,098
Works
159
Citations
11k
Citations per work
68.7
h-index
37
i10-index 48Top 8.9% in Molecular Biology
Lloyd C. Trotman

What does Lloyd C. Trotman research?

Lloyd C. Trotman's work is mostly in Biochemistry, Genetics and Molecular Biology (59%), Medicine (14%), Immunology and Microbiology (4%).

Life Sciences: 100 works · 63.0% of their workBiochemistry, Genetics and Molecular Biology: 94 works · 58.9% of their workMolecular Biology: 76 works · 48.1% of their workCancer Research: 14 works · 8.7% of their workGenetics: 3 works · 2.1% of their workImmunology and Microbiology: 7 works · 4.1% of their workImmunology: 7 works · 4.1% of their workEverything else: 37 works · 23.3% of their workHealth Sciences: 22 works · 13.7% of their workMedicine: 22 works · 13.7% of their workPulmonary and Respiratory Medicine: 13 works · 7.9% of their workOncology: 9 works · 5.8% of their workTHEIR WORKLloyd C. Trotman159works
Life Sciences63%Health Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology9458.9%
    2. Immunology and Microbiology74.1%
  2. Everything else3723.3%
    1. Medicine2213.7%
  1. 1Molecular Biology48% of their works
  2. 2Cancer Research9% of their works
  3. 3Pulmonary and Respiratory Medicine8% of their works
  4. 4Oncology6% of their works
  5. 5Immunology4% of their works
  6. 6Genetics2% of their works

Research topics

Which keywords describe Lloyd C. Trotman's research?

The keywords of their largest research topics: Cancer, mTOR, Signaling, Immunotherapy, Androgen Receptor, Prostate Cancer, Proteasome and Ubiquitin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer493 topics
  2. Signaling291 topic
  3. mTOR291 topic
  4. Immunotherapy202 topics
  5. Androgen Receptor151 topic
  6. Prostate Cancer151 topic
  7. Proteasome141 topic
  8. Ubiquitin141 topic
  9. Fatty Acid Synthase131 topic
  10. Lipid Metabolism131 topic
  11. Alternative Splicing81 topic
  12. RNA methylation81 topic
  13. RNA-Binding Proteins81 topic
  14. m6A-seq81 topic
  15. PTPN1171 topic
  16. Protein Tyrosine Phosphatases71 topic
  17. Bacterial Therapy51 topic
  18. Tumor Targeting51 topic

Where does Lloyd C. Trotman work?

Lloyd C. Trotman's main affiliation in the publication record is Cold Spring Harbor Laboratory, United States.

How many publications and citations does Lloyd C. Trotman have?

OpenAlex counts 159 works and 10,924 citations for Lloyd C. Trotman, an h-index of 37, ranking #167,390 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lloyd C. Trotman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.